RecallDepth
Class III Terminated

Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per carton, Rx only, Mfd for: Watson Laboratories, Inc., Corona, CA 92880, Mfd by: Patheon Pharmaceuticals, Inc., Cincinnati, OH 43215, NDC 0591-0844-15

Company
Teva Pharmaceuticals Usa
Recall Initiated
August 2, 2017
Posted
August 16, 2017
Recall Number
D-1058-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2,880 cartons (30 unit dose blister pack per carton)
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Moisture Limits: out of specification test results for water content obtained during stability testing.

Distribution

Product distributed to OH, IL, PA, MI, VA and CT

Lot / Code Info

Lot # 3138405A, Exp 8/2017

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class III Drug recalls